IBDEI0HW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8662,1,3,0)
 ;;=3^Marginal Corneal Ulcer
 ;;^UTILITY(U,$J,358.3,8662,1,4,0)
 ;;=4^370.01
 ;;^UTILITY(U,$J,358.3,8662,2)
 ;;=Marginal Corneal Ulcer^268908
 ;;^UTILITY(U,$J,358.3,8663,0)
 ;;=375.30^^52^585^47
 ;;^UTILITY(U,$J,358.3,8663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8663,1,3,0)
 ;;=3^Dacrocystitis
 ;;^UTILITY(U,$J,358.3,8663,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,8663,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,8664,0)
 ;;=376.01^^52^585^69
 ;;^UTILITY(U,$J,358.3,8664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8664,1,3,0)
 ;;=3^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,8664,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,8664,2)
 ;;=Orbital Cellulitis^259068
 ;;^UTILITY(U,$J,358.3,8665,0)
 ;;=682.0^^52^585^6
 ;;^UTILITY(U,$J,358.3,8665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8665,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,8665,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,8665,2)
 ;;=Cellulitis of Face^271888
 ;;^UTILITY(U,$J,358.3,8666,0)
 ;;=473.9^^52^585^84
 ;;^UTILITY(U,$J,358.3,8666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8666,1,3,0)
 ;;=3^Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,8666,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,8666,2)
 ;;=Sinusitis^123985
 ;;^UTILITY(U,$J,358.3,8667,0)
 ;;=017.30^^52^585^90
 ;;^UTILITY(U,$J,358.3,8667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8667,1,3,0)
 ;;=3^Tuberculosis,Eye
 ;;^UTILITY(U,$J,358.3,8667,1,4,0)
 ;;=4^017.30
 ;;^UTILITY(U,$J,358.3,8667,2)
 ;;=^122722
 ;;^UTILITY(U,$J,358.3,8668,0)
 ;;=076.9^^52^585^88
 ;;^UTILITY(U,$J,358.3,8668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8668,1,3,0)
 ;;=3^Trachoma,Unspec
 ;;^UTILITY(U,$J,358.3,8668,1,4,0)
 ;;=4^076.9
 ;;^UTILITY(U,$J,358.3,8668,2)
 ;;=^120805
 ;;^UTILITY(U,$J,358.3,8669,0)
 ;;=077.0^^52^585^31
 ;;^UTILITY(U,$J,358.3,8669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8669,1,3,0)
 ;;=3^Conjunctivitis,Inclusion
 ;;^UTILITY(U,$J,358.3,8669,1,4,0)
 ;;=4^077.0
 ;;^UTILITY(U,$J,358.3,8669,2)
 ;;=^27600
 ;;^UTILITY(U,$J,358.3,8670,0)
 ;;=077.1^^52^585^61
 ;;^UTILITY(U,$J,358.3,8670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8670,1,3,0)
 ;;=3^Keratoconjunctivitis,Epidemic EKC
 ;;^UTILITY(U,$J,358.3,8670,1,4,0)
 ;;=4^077.1
 ;;^UTILITY(U,$J,358.3,8670,2)
 ;;=^41251
 ;;^UTILITY(U,$J,358.3,8671,0)
 ;;=077.8^^52^585^37
 ;;^UTILITY(U,$J,358.3,8671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8671,1,3,0)
 ;;=3^Conjunctivitis,Viral,Oth
 ;;^UTILITY(U,$J,358.3,8671,1,4,0)
 ;;=4^077.8
 ;;^UTILITY(U,$J,358.3,8671,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,8672,0)
 ;;=078.5^^52^585^46
 ;;^UTILITY(U,$J,358.3,8672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8672,1,3,0)
 ;;=3^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,8672,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,8672,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,8673,0)
 ;;=090.3^^52^585^59
 ;;^UTILITY(U,$J,358.3,8673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8673,1,3,0)
 ;;=3^Keratitis,Interstitial,Syphilitic
 ;;^UTILITY(U,$J,358.3,8673,1,4,0)
 ;;=4^090.3
 ;;^UTILITY(U,$J,358.3,8673,2)
 ;;=^266697
 ;;^UTILITY(U,$J,358.3,8674,0)
 ;;=091.50^^52^585^93
 ;;^UTILITY(U,$J,358.3,8674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8674,1,3,0)
 ;;=3^Uveitis Syphilitica,Unspec
 ;;^UTILITY(U,$J,358.3,8674,1,4,0)
 ;;=4^091.50
 ;;^UTILITY(U,$J,358.3,8674,2)
 ;;=^266715
 ;;^UTILITY(U,$J,358.3,8675,0)
 ;;=094.83^^52^585^83
 ;;^UTILITY(U,$J,358.3,8675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8675,1,3,0)
 ;;=3^Retinochoroiditis,Dissem,Syphilitic
 ;;^UTILITY(U,$J,358.3,8675,1,4,0)
 ;;=4^094.83
